Recovery Cycle (recovery + cycle)

Distribution by Scientific Domains


Selected Abstracts


PHOTOSYNTHETIC FUNCTION IN DUNALIELLA TERTIOLECTA (CHLOROPHYTA) DURING A NITROGEN STARVATION AND RECOVERY CYCLE

JOURNAL OF PHYCOLOGY, Issue 5 2003
Erica B. Young
Phytoplankton can be exposed to periods of N starvation with episodic N resupply. N starvation in Dunaliella tertiolecta (Butcher) measured over 4 days was characterized by slow reduction in cell chl and protein content and chl/carotenoid ratio and a decline in photosynthetic capacity and maximum quantum yield of photosynthesis (Fv/Fm). In the early stages of N starvation, cell division was maintained despite reduction in cellular chl. Chl content was more sensitive than carotenoids to N deprivation, and cellular chl a was maintained preferentially over chl b under N starvation. NO3, resupply stimulated rapid and complete recovery of Fv/Fm (from 0.4 to 0.7) within 24 h and commencement of cell division after 10 h, although N-replete levels of cell chl and protein were not reestablished within 24 h. Recovery of Fv/Fm was correlated with increases in cell chl and protein and was more related to increases in Fm than to changes in F0. Recovery of Fv/Fm was biphasic with a second phase of recovery commencing 4,6 h after resupply of NO3,. Uptake of NO3, from the external medium and the recovery of Fv/Fm, cell chl, and protein were inhibited when either cytosolic or chloroplastic protein synthesis was inhibited by cycloheximide or lincomycin, respectively; a time lag observed before maximum NO3, uptake was consistent with synthesis of NO3, transporters and assimilation enzymes. When both chloroplastic and cytosolic translation was inhibited, Fv/Fm declined dramatically. Dunaliella tertiolecta demonstrated a capacity to rapidly reestablish photosynthetic function and initiate cell division after N resupply, an important strategy in competing for limiting inorganic N resources. [source]


Electrical activation of the orbicularis oculi muscle does not increase the effectiveness of botulinum toxin type A in patients with blepharospasm

EUROPEAN JOURNAL OF NEUROLOGY, Issue 3 2010
A. Conte
Background:, Our primary aim in this study was to determine whether electrically induced activation of the injected muscle increases effectiveness of botulinum type A toxin (BonT-A) in patients with blepharospasm (BPS). The second aim was to assess the safety of BonT-A by investigating whether BonT-A injection alters the excitability of blink reflex circuits in the brainstem. Methods:, Twenty-three patients with BPS received BonT-A (Botox) injected bilaterally into the orbicularis oculi muscle at a standard dose. In 18 patients, electrically induced muscle activation of the orbicularis oculi muscle on one side was performed for 60 min (4 Hz frequency) in a single session, immediately after BonT-A injection and in five patients for 60 min once a day for five consecutive days. The severity of BPS was assessed clinically with the BPS score. Compound muscle action potential (cMAPs) from the orbicularis oculi muscles were measured bilaterally. The blink reflex recovery cycle was studied at interstimulus intervals of 250 and 500 ms. Participants underwent clinical and neurophysiological assessment before BonT-A injection (T0) and 2 weeks thereafter (T1). Results:, Compound muscle action potential amplitude significantly decreased at T1 but did not differ between stimulated and non-stimulated orbicularis oculi in the two groups. BonT-A injection left the blink reflex recovery cycle tested on the stimulated and non-stimulated sides unchanged. Conclusions:, In patients with BPS, the electrically induced muscle activation neither increases the effectiveness of BonT-A nor produces larger electrophysiological peripheral effects. The lack of BonT-A-induced changes in the blink reflex recovery cycle provides evidence that BonT-A therapy is safe in patients with BPS. [source]


Sensitivity analysis of investments in the pulp and paper industry On investments in the chemical recovery cycle at a board mill

INTERNATIONAL JOURNAL OF ENERGY RESEARCH, Issue 14 2002
M. Karlsson
Abstract In the pulp and paper industry, energy costs represents a relatively large proportion of the value of production. When investing in new equipment, considerations concerning boundary conditions, such as electricity and oil prices, are therefore of great importance. A vital requirement is the identification of other key parameters influencing production costs as well as possible interaction between these parameters. In this paper, a sensitivity analysis is accomplished by using an optimization model that minimizes the system cost combined with a systematic approach involving a statistical method. The paper analyses the possibilities of investing in a new chemical recovery cycle, including a new recovery boiler and evaporation plant, at a Swedish board mill. The study includes a survey of future changes, together with forecasts of boundary conditions, such as changes in the price of electricity and oil. Interactions between different parameters are also examined. Copyright © 2002 John Wiley & Sons, Ltd. [source]


Alteration of central motor excitability in a patient with hemimasticatory spasm after treatment with botulinum toxin injections

MOVEMENT DISORDERS, Issue 1 2006
Pablo Mir MD
Abstract Hemimasticatory spasm (HMS) is a condition characterized by paroxysmal involuntary contraction of masticatory muscles. We performed an electrophysiological investigation of a single patient with HMS to identify any pathophysiological changes associated with the condition. We identified a delayed M wave and jaw jerk on the affected side and an absent masseteric silent period during spasm. Botulinum toxin injections successfully treated the clinical symptoms and resulted in a significant reduction in the excitability of the blink reflex recovery cycle. These data suggest that HMS may be due to ectopic activity in the motor portion of the trigeminal nerve that is capable of inducing changes in the excitability of central reflex pathways. These changes can be altered by successful treatment with botulinum toxin. © 2005 Movement Disorder Society [source]